Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
52-week range
$82.16 – $101.78
83% from low
Exchange
ARCX
ETF
Borrow rate
3.03%
Moderate
No company description on file.
No one on the platform currently holds IXJ.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-09-30 | 6,500 | $576.0K |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-15 | $0.8461 | 2026-06-18 |
| 2025-12-16 | $0.5976 | 2025-12-19 |
| 2025-06-16 | $0.7628 | 2025-06-20 |
| 2024-12-17 | $0.6173 | 2024-12-20 |
| 2024-06-11 | $0.6723 | 2024-06-17 |
| 2023-12-20 | $0.5562 | 2023-12-27 |
| Execution date | Ratio |
|---|---|
| 2018-05-02 | 2-for-1 |
No one on the platform has traded IXJ yet.
| -0.60% |
| $4.1B |
| — |
| IMCGiShares Morningstar Mid-Cap Growth ETF | $98.30 | +1.02% | $3.8B | — |
| ITBiShares U.S. Home Construction ETF | $104.48 | +0.49% | $2.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Waning selling pressures heading into the optimal holding period for Health Care providing an intriguing setup. https://equityclock.com/2026/05/05/stock-market-outlook-for-may-6-2026/ $XLV $VHT $IXJ
View on StockTwits ↗$IXJ healthcare is the sector beaten down. time to load up NOW
View on StockTwits ↗QB Healthcare Model $IXJ $IBB $UNH This is a pretty dense model containing 45 unique features. I selected 45 features with the help of AI ranging from basic broad market indicators to sector specific indicators. After inputting those features and training them on 5-years worth of data using the Machine Learning algo XGBoost, it weighted the 45 features in my model according to "importance" and weights them appropriately. The Healthcare Sector 50-day MA was the top feature with a 5.1% weighting. First Image : Portfolio Backtest on the model created. (Through early March) 2nd Image : Live Performance since late February with a 20-pick per day cap (purple bar chart) - This is the same as the back test 3rd Image: 30 - day 4th Image: April 28th picks & 1-day Returns 5th Image : April 29th Picks (in comments)
View on StockTwits ↗$IXJ Share Price: $101.67 Contract Selected: Sep 18, 2026 $100 Calls Buy Zone: $3.82 – $4.73 Target Zone: $6.81 – $8.32 Potential Upside: 68% ROI Time to Expiration: 199 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$IXJ Current Stock Price: $99.34 Contracts to trade: $99.0 IXJ Feb 20 2026 Call Entry: $2.07 Exit: $2.62 ROI: 26% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗INMD Stock Jumped Nearly 13% Today – What’s Powering The Rally? $INMD $XLV $VHT $IHI $IXJ https://stocktwits.com/news/equity/markets/inmd-stock-jumped-today-what-is-powering-the-rally/cmy7tBNR4h4
View on StockTwits ↗Why Did Corcept Therapeutics Stock Surge Over 14% Today? $CORT $XLV $VHT $IYH $IXJ https://stocktwits.com/news/equity/markets/why-did-corcept-therapeutics-stock-surge-today/cmUC2kwR4XB
View on StockTwits ↗Janux Stock Is Rising Pre-Market After A New Oncology Deal With Bristol Myers Squibb $JANX $XLV $VHT $IXJ $IYH https://stocktwits.com/news/equity/markets/why-janx-stock-rising-premarket-bristol-myers-oncology-deal/cmUzUpeR4QD
View on StockTwits ↗Retail Traders Are Piling Into TG Therapeutics – What’s Driving The Chatter? $TGTX $XLV $VHT $IXJ $IHI https://stocktwits.com/news/equity/markets/tgtx-stock-trending-retail-chatter-2026-revenue-outlook/cmULLfSR4el
View on StockTwits ↗#Betting On A #Boom: 3 #Healthcare #ETFs For 2026 And Beyond $IXJ $VHT $XLV Also $AZN $LLY https://talkmarkets.com/content/etfs/betting-on-a-boom-3-healthcare-etfs-for-2026-and-beyond?post=549419&userid=123969
View on StockTwits ↗$VHT $XLV $IXJ How To Be A Contrarian https://heisenbergreport.com/2025/11/10/how-to-be-a-contrarian/
View on StockTwits ↗Trump Steps Up Pressure On Trading Partners Over Drug Costs, Plans Section 301 Review: Report $XLV $IXJ https://stocktwits.com/news/equity/markets/trump-steps-up-pressure-on-trading-partners-over-drug-costs-plans-section-301-review/cLG5Gc8R3pr
View on StockTwits ↗Trump Walks Back Plan To Slap Tariffs On Generic Drugs After White House Clash Over Prices, Supply Risks: Report $ $XLV $IXJ https://stocktwits.com/news/equity/markets/trump-walks-back-generic-drug-tariffs-after-white-house-clash-over-prices-supply-risks/ch67JdhR30E
View on StockTwits ↗AI + cancer research = massive tailwind for $VHT, $IXJ, $XBI 🚀 A federal push for pediatric oncology alongside AI’s expanding role in research is driving momentum in these healthcare ETFs. See the full healthcare ETF breakdown here 👉 https://www.zacks.com/stock/news/2760047/unlocking-cures-how-ai-is-reshaping-cancer-research-healthcare-etfs?art_rec=home-home-investment_ideas_stocks-ID15-txt-2760047&cid=sm-stocktwits-2-2760047-teaser-14551&ADID=SYND_STOCKTWITS_TWEET_2_2760047_TEASER_14551
View on StockTwits ↗Exec order boosts pediatric cancer focus — what it means for $VHT & $IXJ 📈 President Trump's $50M push for childhood cancer data, leveraging AI, aims to enhance clinical trials and data analysis. This move is set to benefit healthcare ETFs like Vanguard Health Care ETF and iShares Global Healthcare ETF, both with significant exposure to major healthcare firms adopting AI-driven diagnostics. Discover the ETF impact here 👉 https://www.zacks.com/stock/news/2760047/unlocking-cures-how-ai-is-reshaping-cancer-research-healthcare-etfs?cid=sm-stocktwits-2-2760047-body-14550&ADID=SYND_STOCKTWITS_TWEET_2_2760047_BODY_14550
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.